Integrated Filing — IndAS



General information about company

Scrip Code 542655
NSE Symbol VIKASLIFE
MSEI Symbol NA
ISIN INE161L01027
Name of company Vikas Lifecare Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 28-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 24-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 28-May-2025   21:50:00
End date and time of board meeting 28-May-2025   23:20:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public No
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. No
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-05-28
Indicate Company website link for updated RPT policy of the Company www.vikaslifecarelimited.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? Yes



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 1296691000 4635762000
Other income 209770000 263265000
Total income 1506461000 4899027000
2 Expenses
(a) Cost of materials consumed 2884000 55934000
(b) Purchases of stock-in-trade 1215588000 4464167000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 44276000 -8909000
(d) Employee benefit expense 5679000 22346000
(e) Finance costs 11034000 39070000
(f) Depreciation, depletion and amortisation expense 20761000 65247000
(f) Other Expenses
1 Other Expenses 214687000 296696000
Total other expenses 214687000 296696000
Total expenses 1514909000 4934551000
3 Total profit before exceptional items and tax -8448000 -35524000
4 Exceptional items 0 0
5 Total profit before tax -8448000 -35524000
6 Tax expense
7 Current tax 7687000 37811000
8 Deferred tax -25273000 -50769000
9 Total tax expenses -17586000 -12958000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 9138000 -22566000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 9138000 -22566000
17 Other comprehensive income net of taxes 37735000 37735000
18 Total Comprehensive Income for the period 46873000 15169000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1859836000 1859836000
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 3589836000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -0.01 -0.01
Diluted earnings (loss) per share from continuing operations -0.01 -0.01
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -0.01 -0.01
Diluted earnings (loss) per share from continuing and discontinued operations -0.01 -0.01
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 353648000
Capital work-in-progress 6531000
Investment property 71513000
Goodwill 0
Other intangible assets 0
Intangible assets under development 68669000
Biological assets other than bearer plants 4737000
Investments accounted for using equity method 484065000
Non-current financial assets
Non-current investments 0
Trade receivables, non-current 30003000
Loans, non-current 39065000
Other non-current financial assets 2833816000
Total non-current financial assets 2902884000
Deferred tax assets (net) 34489000
Other non-current assets 490160000
Total non-current assets 4416696000
2 Current assets
Inventories 47813000
Current financial asset
Current investments 0
Trade receivables, current 1232267000
Cash and cash equivalents 52402000
Bank balance other than cash and cash equivalents 0
Loans, current 0
Other current financial assets 276804000
Total current financial assets 1561473000
Current tax assets (net) 870414000
Other current assets 32820000
Total current assets 2512520000
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 6929216000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1859836000
Other equity 3589828000
Total equity attributable to owners of parent 5449664000
Non controlling interest
Total equity 5449664000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities 385171000
Total non-current financial liabilities 385171000
Provisions, non-current 2002000
Deferred tax liabilities (net) 1805000
Deferred government grants, Non-current 3046000
Other non-current liabilities 39000000
Total non-current liabilities 431024000
Current liabilities
Current financial liabilities
Borrowings, current 49678000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 6574000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 565868000
Total Trade payable 572442000
Other current financial liabilities 101698000
Total current financial liabilities 723818000
Other current liabilities 167000
Provisions, current 1813000
Current tax liabilities (Net) 253605000
Deferred government grants, Current 69125000
Total current liabilities 1048528000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 1479552000
Total equity and liabilites 6929216000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Real Estate Division 0 0
2 Trading & Manufacturing Division- Polymers 41709000 175387000
3 Trading & Manufacturing Division - Agro 1038180000 3790890000
4 Trading & manufacturing Division- Infrastructure 216802000 669485000
Total Segment Revenue 1296691000 4635762000
Less: Inter segment revenue
Revenue from operations 1296691000 4635762000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Real Estate Division 0 0
2 Trading & Manufacturing Division- Polymers -5411000 3261000
3 Trading & Manufacturing Division - Agro 36936000 109150000
4 Trading & manufacturing Division- Infrastructure 2418000 12158000
Total Profit before tax 33943000 124569000
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax 33943000 124569000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Real Estate Division 0 0
2 Trading & Manufacturing Division- Polymers 0 0
3 Trading & Manufacturing Division - Agro 0 0
4 Trading & manufacturing Division- Infrastructure 0 0
Total Segment Asset 0 0
Un-allocable Assets 0 0
Net Segment Asset 0 0
4 Segment Liabilities
Segment Liabilities
1 Real Estate Division 0 0
2 Trading & Manufacturing Division- Polymers 0 0
3 Trading & Manufacturing Division - Agro 0 0
4 Trading & manufacturing Division- Infrastructure 0 0
Total Segment Liabilities 0 0
Un-allocable Liabilities 0 0
Net Segment Liabilities 0 0
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss -37735000 -37735000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income 37735000 37735000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax -35524000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 0
Adjustments for decrease (increase) in inventories 65247000
Adjustments for decrease (increase) in trade receivables, current 0
Adjustments for decrease (increase) in trade receivables, non-current 38795000
Adjustments for decrease (increase) in other current assets -1837000
Adjustments for decrease (increase) in other non-current assets -101630000
Adjustments for other financial assets, non-current -311000
Adjustments for other financial assets, current 40526000
Adjustments for other bank balances 40526000
Adjustments for increase (decrease) in trade payables, current 291000
Adjustments for increase (decrease) in trade payables, non-current -5305000
Adjustments for increase (decrease) in other current liabilities -6482000
Adjustments for increase (decrease) in other non-current liabilities -51000000
Adjustments for depreciation and amortisation expense 275000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss -413000
Adjustments for provisions, current -37623000
Adjustments for provisions, non-current 241503000
Adjustments for other financial liabilities, current 42476000
Adjustments for other financial liabilities, non-current 124472000
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for interest income 0
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 601000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow -3133408000
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 447246000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -2296051000
Net cash flows from (used in) operations -2331575000
Dividends received 0
Interest paid -3075000
Interest received 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities -2328500000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 52736000
Purchase of property, plant and equipment 0
Proceeds from sales of investment property 1682000
Purchase of investment property 0
Proceeds from sales of intangible assets 1438983000
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 2475000
Purchase of intangible assets under development -5305000
Proceeds from sales of goodwill 37623000
Purchase of goodwill 127000000
Proceeds from biological assets other than bearer plants 51000000
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets -411000
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) investing activities 1463215000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 208051000
Repayments of borrowings 4592000
Payments of lease liabilities 0
Dividends paid 38795000
Interest paid 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash 620000000
Net cash flows from (used in) financing activities 784664000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -80621000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -80621000
Cash and cash equivalents cash flow statement at beginning of period 0
Cash and cash equivalents cash flow statement at end of period -80621000





Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 KSMC & Associates Yes 31-May-2027


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Vikas Lifecare Limited Genesis Gas solution Private Limited Subsidiary Company Any other transaction Reimbursement of Expenes Favourable 747000 0 0
2 Vikas Lifecare Limited Genesis Gas solution Private Limited Subsidiary Company Loan Favourable 120711000 0 0
3 Vikas Lifecare Limited Genesis Gas solution Private Limited Subsidiary Company Any other transaction loan repaid Favourable 148095000 0 0
4 Vikas Lifecare Limited Genesis Gas solution Private Limited Subsidiary Company Any other transaction rent Favourable 330000 0 0
5 Vikas Lifecare Limited Genesis Gas solution Private Limited Subsidiary Company Any other transaction interest on loan Favourable 5967000 0 0
6 Vikas Lifecare Limited Genesis Gas solution Private Limited Subsidiary Company Any other transaction balance outstanding Favourable 686000 0 0
7 Vikas Lifecare Limited Seema Garg Wife of promoter Any other transaction rent Favourable 272000 0 0
8 Vikas Lifecare Limited Vivek Garg Brother of Promoter Any other transaction rent Favourable 162000 0 0
9 Vikas Lifecare Limited Sundeep Kumar Dhawan Managing Director Remuneration Favourable 1100000 0 0
10 Vikas Lifecare Limited Chandan Kumar CFO cum Director Remuneration Favourable 1300000 0 0
11 Vikas Lifecare Limited Sanjay Jaiswal Company Secretary Remuneration Favourable 500000 0 0
12 Vikas Lifecare Limited Parag Dadeech Director Remuneration Favourable 2933000 0 0
13 Vikas Lifecare Limited Vikas Ecotech Limited Related Party Any other transaction Reimbursement of Expenes Favourable 294000 0 0
14 Vikas Lifecare Limited Vrindaa Advanced Materials Limited Related Party Purchase of goods or services Favourable 987000 0 0
15 Vikas Lifecare Limited Just Right Life Limited Related Party Any other transaction sale of share Favourable 125000000 0 0
16 Vikas Lifecare Limited Vikas Ecotech Limited Related Party Purchase of goods or services Favourable 65925000 0 0
17 Vikas Lifecare Limited Vikas Ecotech Limited Related Party Sale of goods or services Favourable 19464000 0 0
18 Vikas Lifecare Limited Vrindaa Advanced Materials Limited Related Party Sale of goods or services Favourable 444250000 0 0
19 Vikas Lifecare Limited Shashi Beriwal Private Limited Subsidiary Company Loan Favourable 68000 0 0
20 Vikas Lifecare Limited Shashi Beriwal Private Limited Subsidiary Company Loan Favourable 27400000 0 0
21 Vikas Lifecare Limited Shashi Beriwal Private Limited Subsidiary Company Loan Favourable 18000000 0 0
22 Vikas Lifecare Limited Shashi Beriwal Private Limited Subsidiary Company Loan Favourable 84986000 0 0
23 Vikas Lifecare Limited Shashi Beriwal Private Limited Subsidiary Company Loan Favourable 679000 0 0
24 Vikas Lifecare Limited Shashi Beriwal Private Limited Subsidiary Company Loan Favourable -27400000 0 0
Total value of transaction during the reporting period 1042456000





Format for Disclosing Outstanding Default on Loans and Debt Securities

Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date 0
B Of the total amount outstanding, amount of default as on date 0
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date 0
B Of the total amount outstanding, amount of default as on date 0
3. Total financial indebtedness of the listed entity including short-term and long-term debt 0